HIKAL
Back to Balance Sheet
|
HIKAL Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹543 Cr | ₹590 Cr | ₹432 Cr | ₹379 Cr | ₹410 Cr |
What is the latest Total Non-Current Liabilities ratio of HIKAL ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹543 Cr |
Mar2023 | ₹590 Cr |
Mar2022 | ₹432 Cr |
Mar2021 | ₹379 Cr |
Mar2020 | ₹410 Cr |
How is Total Non-Current Liabilities of HIKAL Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹543 Cr | -8.06 | |
Mar2023 | ₹590 Cr | 36.71 | |
Mar2022 | ₹432 Cr | 13.96 | |
Mar2021 | ₹379 Cr | -7.60 | |
Mar2020 | ₹410 Cr | - |
Compare Total Non-Current Liabilities of peers of HIKAL
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
HIKAL | ₹3,990.0 Cr | -4.1% | -10.8% | -6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹408,595.0 Cr | 1.5% | 0.9% | 2% | Stock Analytics | |
DIVIS LABORATORIES | ₹174,635.0 Cr | -0.5% | -1.2% | 45.5% | Stock Analytics | |
CIPLA | ₹126,894.0 Cr | 7.2% | 4.5% | 2.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,685.0 Cr | 3.5% | 8.4% | 16.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,373.0 Cr | 3.7% | -1.1% | -6.8% | Stock Analytics |
HIKAL Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
HIKAL | -4.1% |
-10.8% |
-6% |
SENSEX | -1.6% |
-3.4% |
0.9% |
You may also like the below Video Courses